Aurinia Pharmaceuticals, Inc. (AUPH)
15.98
-0.16
(-0.99%)
USD |
NASDAQ |
Apr 24, 16:00
16.00
+0.02
(+0.09%)
After-Hours: 20:00
Aurinia Pharmaceuticals EPS Diluted (Quarterly) : 1.526 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -1.314 |
| Oncolytics Biotech, Inc. | -0.0139 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0593 |
| ProMIS Neurosciences, Inc. | -4.959 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 210.79M |
| Revenue (Quarterly) | 77.11M |
| Total Expenses (Quarterly) | -133.68M |
| Enterprise Value | 1.802B |
| Gross Profit Margin (Quarterly) | 88.59% |
| Earnings Yield | 13.00% |
| Operating Earnings Yield | 5.24% |
| Normalized Earnings Yield | 13.05 |